- Home
- PPSI vs FGEN Comparison
PPSI vs FGEN Comparison
Compare PPSI & FGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PPSI
- FGEN
- Stock Information
- Founded
- PPSI 2008
- FGEN 1993
- Country
- PPSI United States
- FGEN United States
- Employees
- PPSI N/A
- FGEN N/A
- Industry
- PPSI Electrical Products
- FGEN Biotechnology: Pharmaceutical Preparations
- Sector
- PPSI Industrials
- FGEN Health Care
- Exchange
- PPSI Nasdaq
- FGEN Nasdaq
- Market Cap
- PPSI 30.0M
- FGEN 33.5M
- IPO Year
- PPSI N/A
- FGEN 2014
- Fundamental
- Price
- PPSI $2.71
- FGEN $5.85
- Analyst Decision
- PPSI Strong Buy
- FGEN Strong Buy
- Analyst Count
- PPSI 1
- FGEN 1
- Target Price
- PPSI $12.00
- FGEN $250.00
- AVG Volume (30 Days)
- PPSI 37.9K
- FGEN 61.5K
- Earning Date
- PPSI 05-15-2025
- FGEN 08-05-2025
- Dividend Yield
- PPSI 54.74%
- FGEN N/A
- EPS Growth
- PPSI N/A
- FGEN N/A
- EPS
- PPSI 2.84
- FGEN N/A
- Revenue
- PPSI $26,304,000.00
- FGEN $6,996,000.00
- Revenue This Year
- PPSI $24.01
- FGEN N/A
- Revenue Next Year
- PPSI $19.25
- FGEN N/A
- P/E Ratio
- PPSI $0.96
- FGEN N/A
- Revenue Growth
- PPSI 439.46
- FGEN N/A
- 52 Week Low
- PPSI $2.25
- FGEN $4.50
- 52 Week High
- PPSI $7.00
- FGEN $38.25
- Technical
- Relative Strength Index (RSI)
- PPSI 50.31
- FGEN 43.29
- Support Level
- PPSI $2.65
- FGEN $5.37
- Resistance Level
- PPSI $2.76
- FGEN $5.73
- Average True Range (ATR)
- PPSI 0.10
- FGEN 0.41
- MACD
- PPSI 0.00
- FGEN 0.07
- Stochastic Oscillator
- PPSI 61.54
- FGEN 77.78
About PPSI Pioneer Power Solutions Inc.
Pioneer Power Solutions Inc designs, manufactures, integrates, services, and sells distributed energy resources, on-site and mobile power generation equipment, and a platform of mobile electric vehicle (EV) charging solutions.. Its principal products and services include custom-engineered electrical transformers, switchgear and engine-generator sets and controls, complemented by a national field-service network to maintain and repair power generation assets.
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.